GEN Exclusives

More »

GEN News Highlights

Back to Item »

Biolex to Take Over Full Rights to Investigational Hep C. Drug from Octoplus for $11M

Octoplus will provide manufacturing and process development services and stands to earn $138 million in milestones.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »